Sinclair Pharma acquires rights to the Refine Support System
Source - SMW
Sinclair Pharma has acquired the Refine Support System for a total consideration of up to $11.3m including regulatory and sales based milestones and royalties.
The system was a patented and FDA cleared, suture-based product primarily used in breast cosmetic and reconstructive procedures.
It was owned by Refine LLC, and was a soft and flexible suture-mesh-anchor system that lifted and supported soft tissue.
The Refine Support System would be incorporated into the Silhouette portfolio.
The system could be used for a number of cosmetic or reconstruction soft tissue procedures, and could be used both as a standalone procedure or to help enhance many other regularly performed cosmetic and reconstructive procedures such as a breast lift and combined breast reduction and lift.